Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Glucagon-like peptide-1 receptor agonist, semaglutide, attenuates intravenous self-administration of fentanyl in female rats
bioRxiv : the preprint server for biology, 2026
Tirzepatide and Cardiometabolic Effects in Obese Non-diabetic Adults: A Systematic Review, Meta-Analysis, and Narrative Synthesis of Cardiovascular Outcomes
Cureus, 2026;18(5):e109350
BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers
Pharmaceutics, 2026;18(5)
A rationally designed 18-amino acid peptide with potential as GLP-1 receptor agonist
Frontiers in pharmacology, 2026;17:1789257
Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications
JBJS reviews, 2026;14(5)
Clinical impact of tirzepatide on patients with chronic obstructive pulmonary disease
Frontiers in pharmacology, 2026;17:1838392
Psychosocial Outcomes in Telemedicine and Long-Acting Incretin-Specific Behavioral Intervention
Obesity science & practice, 2026;12(3):e70149
Efficacy and safety of novel formulation of semaglutide injection: A multicentre, randomized, comparative, active controlled, phase 3 study in comparison with reference biologic in Indian patients with type 2 diabetes mellitus
Metabolism open, 2026;30:100476
Corrigendum to “Efficacy and safety of semaglutide injection in comparison with reference semaglutide for chronic weight management in Indian adults with obesity: A phase III randomized non-inferiority trial” [Metabol Open 30 (2026) 100460]
Metabolism open, 2026;30:100477
A Case of an Invisible Pancreatic Neuroendocrine Tumor Decoded by Endoscopic Ultrasound
Cureus, 2026;18(5):e109296
Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on the risk of venous thromboembolism in patients with obesity: a real-world cohort study
Frontiers in medicine, 2026;13:1820366
Swiss obesity clinical practice guidance
Swiss medical weekly, 2026;156:5415
Structure-Property-Performance Engineering of Hydrogel Depots for Long-Acting Peptide Delivery
bioRxiv : the preprint server for biology, 2026
Semaglutide and Follow-On Peptide Therapeutics: Balancing Innovation, Regulation, and Clinical Outcomes
Cureus, 2026;18(5):e108999
GLP-1 Receptor Agonists in Hidradenitis Suppurativa: Time to Treat the Whole Patient
Skin appendage disorders, 2026
Efficacy and Safety of Oral Semaglutide in the Management of Diabetes and Obesity: A Comprehensive Meta-analysis of Real-world Evidence
TouchREVIEWS in endocrinology, 2026;22(1):16-28
Early changes in body composition with tirzepatide in adults with obesity: a real-world BIA study
Nutrition (Burbank, Los Angeles County, Calif.), 2026;150:113286
Ketoacidosis Risk in Non-diabetic Patients Using Semaglutide Versus Tirzepatide for Obesity: A Disproportionality Analysis of the FDA Adverse Event Reporting System
Cureus, 2026;18(5):e108868
Multi-Layer Magnetic Shields Based on Fe-Based Nanocrystalline and Co-Based Amorphous Ribbons
Materials (Basel, Switzerland), 2026;19(10)
Semaglutide-induced lean mass loss: clinical concern or physiological adaptation
Annals of medicine and surgery (2012), 2026;88(6):3913-3914